Chronic Myelogenous Leukemia in blast crisis can manifest as either myeloid (more common) or lymphoid blast crisis. Most lymphoblastic crises are of B-cell lineage. T-cell blast crisis is extremely rare, with only a few reported cases. We present a case of a middle-aged man who was diagnosed with CML on peripheral blood and bone marrow biopsy. Because of a generalized lymphadenopathy noted at the time of diagnosis, a lymph node biopsy was also performed, which revealed a T-cell lymphoblastic leukemia/lymphoma, BCR/ABL1 positive, with clonal evolution. This is a very rare manifestation of CML in blast crisis with no standard treatment and with poor outcomes despite chemotherapy or allogeneic stem cell transplant. Given its rarity, it would be difficult to develop standard chemotherapy protocols. We believe the treatment for this condition should be similar to any lymphoid blast crisis. The patient was treated with induction chemotherapy (hyper-CVAD regimen) plus dasatinib for 3 cycles followed by sibling-donor allogeneic stem cell transplant and is currently on maintenance dasatinib and has minimal residual disease at this time.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276408 | PMC |
http://dx.doi.org/10.1155/2018/7276128 | DOI Listing |
Cureus
December 2024
Department of Orthopedics, Jordanain Royal Medical Services, Amman, JOR.
Orthopedic injuries in Gaza, many of which would be straightforward to manage under normal circumstances, have become increasingly complex and challenging due to ongoing conflict, severe healthcare limitations, and delayed treatment. This review highlights cases of injuries that, if treated promptly, could have been managed with standard protocols but have evolved into complicated and difficult-to-treat conditions. Delayed care, lack of resources, and restricted rehabilitation significantly increase the complexity of treatment and lead to higher rates of complications, and impaired outcomes.
View Article and Find Full Text PDFRes Sq
December 2024
The Metrohealth System, Case Western Reser.
Long non-coding RNAs (lncRNAs) and RNA N6-methyladenosine (mA) have been linked to leukemia drug resistance. However, whether and how lncRNAs and mA coordinately regulate resistance remain elusive. Here, we show that many differentially expressed lncRNAs enrich mA, and more lncRNAs tend to have higher mA content in CML cells resistant to tyrosine kinase inhibitors (TKIs).
View Article and Find Full Text PDFJ Perioper Pract
January 2025
Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
J Yeungnam Med Sci
December 2024
Haematology Unit, Department of Pathology, Hospital Sultanah Aminah, Ministry of Health, Johor Bahru, Malaysia.
Chronic myeloid leukemia (CML) typically progresses from a chronic phase to an accelerated phase, and eventually to a blast crisis, often involving the bone marrow and peripheral blood, if left untreated. Central nervous system (CNS) involvement is an uncommon manifestation of CML, particularly as an isolated CNS relapse. Here, we present a rare case of CML in lymphoid blast crisis with an isolated CNS relapse.
View Article and Find Full Text PDFBlood Cell Ther
November 2024
Department of Haematology, Singapore General Hospital, Singapore.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!